Paper9196136
Late effects of allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: the impact of conditioning regimen without total-body irradiation--a report from the Société Française de Greffe de Moelle.
Michel G and 17 others. J Clin Oncol, 1997. Cited by 130 papers, by iCite.
Cite this record
ConductScience Library. Late effects of allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: the impact of conditioning regimen without total-body irradiation--a report from the Société Française de Greffe de Moelle. Papers, record 9196136. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9196136
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Late effects of allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: the impact of conditioning regimen without total-body irradiation--a report from the Société Française de Greffe de Moelle.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bone Marrow Transplantation | Major topic |
| Leukemia, Myeloid, Acute | Major topic |
| Puberty | Major topic |
| Transplantation Conditioning | Major topic |
| Adolescent | |
| Antineoplastic Agents, Alkylating | |
| Antineoplastic Combined Chemotherapy Protocols | |
| Busulfan | |
| Child | |
| Child, Preschool | |
| Cyclophosphamide | |
| Disease-Free Survival | |
| Female | |
| Growth | |
| Humans | |
| Infant | |
| Male | |
| Whole-Body Irradiation |
Source PubMed
Cited by51
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 130 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42255431 | Existing and emerging strategies for fertility preservation in female patients with leukemia. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/42255431 | PubMed |
| 42120917 | Fertility preservation in 2026: current landscape in Europe and the United States for children and adolescents undergoing hematopoietic stem cell transplantation-recommendations on behalf of the Westhafen Intercontinental Group. | Bone Marrow Transplant | 2026 | https://conductscience.org/library/papers/42120917 | PubMed |
| 41713649 | Fertility Preservation in 2026: Current Landscape in Europe and the United States for Children and Adolescents Undergoing Hematopoietic Stem Cell Transplantation - Recommendations on Behalf of the Westhafen Intercontinental Group. | Transplant Cell Ther | 2026 | https://conductscience.org/library/papers/41713649 | PubMed |
| 40962140 | Excellent Outcomes in Feasibility Study of Radiation-Free Conditioning and Transplant in Pediatric Severe Aplastic Anemia. | Transplant Cell Ther | 2026 | https://conductscience.org/library/papers/40962140 | PubMed |
| 40063330 | Effect of conditioning intensity on late complications in AYA who underwent allogeneic HCT during childhood. | Int J Hematol | 2025 | https://conductscience.org/library/papers/40063330 | PubMed |
| 40014081 | Fertility assessment in long-term young female survivors with hematological disease after allogeneic hematopoietic cell transplantation: a single-center real-life cross-sectional study. | Ann Hematol | 2025 | https://conductscience.org/library/papers/40014081 | PubMed |
| 38406392 | Acute Toxicity of Total Body Irradiation Using Volumetric Arc Therapy With a Focus on the Effect of Lung Dose Rate. | Adv Radiat Oncol | 2024 | https://conductscience.org/library/papers/38406392 | PubMed |
| 37711551 | Revisiting treatment-related cardiotoxicity in patients with malignant lymphoma-a review and prospects for the future. | Front Cardiovasc Med | 2023 | https://conductscience.org/library/papers/37711551 | PubMed |
| 36619560 | Thyroid function disorders and secondary cancer following haematopoietic stem cell transplantation in pediatrics: State of the art and practical recommendations for a risk-based follow-up. | Front Endocrinol (Lausanne) | 2022 | https://conductscience.org/library/papers/36619560 | PubMed |
| 35840745 | Late endocrine effects after hematopoietic stem cell transplantation in children with nonmalignant diseases. | Bone Marrow Transplant | 2022 | https://conductscience.org/library/papers/35840745 | PubMed |
| 34900873 | Late Effects After Haematopoietic Stem Cell Transplantation in ALL, Long-Term Follow-Up and Transition: A Step Into Adult Life. | Front Pediatr | 2021 | https://conductscience.org/library/papers/34900873 | PubMed |
| 33824435 | Long-term follow-up of high-risk neuroblastoma survivors treated with high-dose chemotherapy and stem cell transplantation rescue. | Bone Marrow Transplant | 2021 | https://conductscience.org/library/papers/33824435 | PubMed |
| 32396620 | Subsequent neoplasms and late mortality in children undergoing allogeneic transplantation for nonmalignant diseases. | Blood Adv | 2020 | https://conductscience.org/library/papers/32396620 | PubMed |
| 32231250 | Anti-Müllerian hormone and Inhibin B after stem cell transplant in childhood: a comparison of myeloablative, reduced intensity and treosulfan-based chemotherapy regimens. | Bone Marrow Transplant | 2020 | https://conductscience.org/library/papers/32231250 | PubMed |
| 31996791 | Occurrence of long-term effects after hematopoietic stem cell transplantation in children affected by acute leukemia receiving either busulfan or total body irradiation: results of an AIEOP (Associazione Italiana Ematologia Oncologia Pediatrica) retrospective study. | Bone Marrow Transplant | 2020 | https://conductscience.org/library/papers/31996791 | PubMed |
| 31204177 | Antibody Conditioning Enables MHC-Mismatched Hematopoietic Stem Cell Transplants and Organ Graft Tolerance. | Cell Stem Cell | 2019 | https://conductscience.org/library/papers/31204177 | PubMed |
| 29599204 | Late effects after hematopoietic stem cell transplantation for β-thalassemia major: the French national experience. | Haematologica | 2018 | https://conductscience.org/library/papers/29599204 | PubMed |
| 28087456 | Phase I Trial of Total Marrow and Lymphoid Irradiation Transplantation Conditioning in Patients with Relapsed/Refractory Acute Leukemia. | Biol Blood Marrow Transplant | 2017 | https://conductscience.org/library/papers/28087456 | PubMed |
| 25312098 | Growth impairment after TBI of leukemia survivors children: a model- based investigation. | Theor Biol Med Model | 2014 | https://conductscience.org/library/papers/25312098 | PubMed |
| 25295241 | Endocrinopathies in survivors of childhood neoplasia. | Front Pediatr | 2014 | https://conductscience.org/library/papers/25295241 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9196136
GET https://conductscience.org/api/papers/v1/9196136/cited_by?page=2